L

Lupin Ltd

PharmaceuticalsLargecap

About the company

Lupin Limited is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 36 analysts offering recommendations for Lupin Ltd

72%

Buy

22%

Hold

6%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio32.2435.98
PB Ratio6.125.67
Dividend Yield0.52%0.59%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions